Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Biochemistry (Mosc) ; 72(8): 848-53, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17922642

RESUMO

Matrix metalloproteinase-9 (MMP-9) plays an important role in initiation and progression of squamous cell carcinoma (SCC) of human uterine cervix. Regulation of MMP-9 expression in such tumors is insufficiently studied. Involvement of the human papillomavirus (HPV) gene E2 and transcription factor NF-kappaB in the regulation of MMP-9 transcription has been shown in some model systems and types of malignant tumors. The present work was mainly designed to reveal a possible role of the HPV gene E2 and transcription factor NF-kappaB in the induction of MMP-9 expression in SCC. Specimens of tumor and corresponding adjacent normal tissue from 26 patients with SCC of the uterine cervix were studied. The intact E2 frame was observed in 19 of 26 (73.1%), the E2 gene mRNA was expressed in 10 of 15 (66.7%), NF-kappaB was activated in 17 of 23 (73.9%), and the expression of MMP-9 mRNA was recorded in 10 of 20 (50%) of the informative cases. The MMP-9 transcription did not correlate with gene E2 status, but in all cases correlated with the activation of NF-kappaB transcription factor (10 of 10 vs. 5 of 10 MMP-9-negative cases, p = 0.016). Thus, the NF-kappaB role has been proved in the regulation of MMP-9 transcription in SCC. There was no correlation of the E2 status and MMP-9 expression with clinical/morphological characteristics of the tumors: size, local invasiveness, metastasizing into regional lymph nodes, and level of differentiation. The high intensity of NF-kappaB activation correlated with low degree of differentiation of the tumors studied (p = 0.044). These findings suggested that NF-kappaB should be a molecular factor of the poor prognosis of human SCC.


Assuntos
Regulação da Expressão Gênica , Metaloproteinase 9 da Matriz/biossíntese , NF-kappa B/metabolismo , Neoplasias de Células Escamosas/enzimologia , Proteínas Oncogênicas Virais/metabolismo , Transcrição Gênica , Neoplasias Uterinas/enzimologia , Feminino , Regulação da Expressão Gênica/genética , Humanos , NF-kappa B/genética , Neoplasias de Células Escamosas/genética , Neoplasias de Células Escamosas/patologia , Neoplasias de Células Escamosas/virologia , Transcrição Gênica/genética , Neoplasias Uterinas/genética , Neoplasias Uterinas/patologia , Neoplasias Uterinas/virologia
2.
Mol Gen Genet ; 207(1): 130-41, 1987 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3037277

RESUMO

When RSV DNA cloned in pBR 322 or DNA of simian adenovirus Sa7 (C8) is injected into the pole plasm of embryos of various Drosophila stocks, the progeny of 1-70% of the surviving flies display visible mutations. The mutagenesis is partially directed: the loci mutating due to retrovirus and adenovirus DNA do not overlap. The majority of resulting mutants are characterised by high instability: reversions and new mutations occur in them, which sometimes spread over the whole population ("explosive" instability). The injected sequences are revealed by dot-hybridization in the DNA of many mutant strains, but only rarely by Southern blotting procedures. The results show that the microinjection of oncovirus DNA into embryos is an approach for obtaining highly unstable strains even from wild-type stable Drosophila stocks without crosses with MR lines or the introduction of P elements. The sets of unstable mutations induced by oncovirus DNA is different from those in hybrid dysgenesis.


Assuntos
Vírus do Sarcoma Aviário/genética , DNA Viral/farmacologia , Drosophila melanogaster/genética , Adenoviridae/genética , Animais , Citoplasma , DNA Recombinante/análise , DNA Recombinante/farmacologia , DNA Viral/análise , DNA Viral/genética , Drosophila melanogaster/embriologia , Embrião não Mamífero/efeitos dos fármacos , Microinjeções , Mutação , Fenótipo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA